Terminal · Institutions
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
SAMSARA BIOCAPITAL, LLC (CIK 1744967) reported $1.22B across 24 reported positions in its SEC 13F filing for 2026-06-30. Largest positions: SRRK ($379.4M, 31.16%), ALMS ($178.6M, 14.67%), MLYS ($158.4M, 13.01%), SEPN ($105.5M, 8.66%), ALMR ($67.2M, 5.52%). Source: SEC Form 13F.
| Rank | Ticker | Company | Value | % Portfolio | Shares | Action |
|---|---|---|---|---|---|---|
| 1 | SRRK | SCHOLAR ROCK HLDG CORP | $379.4M | 31.16% | 6.9M | Hold |
| 2 | ALMS | ALUMIS INC | $178.6M | 14.67% | 6.3M | Hold |
| 3 | MLYS | MINERALYS THERAPEUTICS INC | $158.4M | 13.01% | 5.9M | Hold |
| 4 | SEPN | SEPTERNA INC | $105.5M | 8.66% | 3.1M | Hold |
| 5 | ALMR | ALAMAR BIOSCIENCES INC | $67.2M | 5.52% | 2.5M | New |
| 6 | NGNE | NEUROGENE INC | $54.0M | 4.44% | 1.7M | Hold |
| 7 | KLRS | KALARIS THERAPEUTICS INC | $52.4M | 4.31% | 12.9M | Trimmed |
| 8 | SGP | SPYGLASS PHARMA INC | $47.0M | 3.86% | 2.1M | Hold |
| 9 | STRO | SUTRO BIOPHARMA INC | $35.3M | 2.90% | 1.1M | Hold |
| 10 | IVA | INVENTIVA SA | $23.9M | 1.96% | 6.3M | Added |
| 11 | JBIO | JADE BIOSCIENCES INC | $16.4M | 1.34% | 736,237 | Trimmed |
| 12 | PBLS | PARABILIS MEDICINES INC | $15.2M | 1.25% | 556,044 | New |
| 13 | VTVT | VTV THERAPEUTICS INC | $11.2M | 0.92% | 298,496 | Hold |
| 14 | AQST | AQUESTIVE THERAPEUTICS INC | $10.4M | 0.85% | 2.5M | Hold |
| 15 | NKTX | NKARTA INC | $9.9M | 0.82% | 3.5M | Hold |
| 16 | ARTV | ARTIVA BIOTHERAPEUTICS INC | $9.3M | 0.76% | 954,861 | New |
| 17 | RANI | RANI THERAPEUTICS HLDGS INC | $7.9M | 0.65% | 10.4M | Added |
| 18 | AGMB | AGOMAB THERAPEUTICS NV | $7.8M | 0.64% | 600,000 | Hold |
| 19 | ABVX | ABIVAX SA | $7.3M | 0.60% | 55,095 | Trimmed |
| 20 | XFOR | X4 PHARMACEUTICALS INC | $6.5M | 0.54% | 1.4M | Trimmed |
| 21 | ELOX | ELOXX PHARMACEUTICALS INC | $5.6M | 0.46% | 400,000 | New |
| 22 | CHRS | COHERUS ONCOLOGY INC | $4.8M | 0.39% | 3.4M | Hold |
| 23 | UPB | UPSTREAM BIO INC | $2.4M | 0.20% | 353,717 | Trimmed |
| 24 | GOSS | GOSSAMER BIO INC | $1.2M | 0.10% | 7.2M | Hold |
| 25 | PVLA | PALVELLA THERAPEUTICS INC NE | $0 | 0.00% | 0 | Exited |
Source: SEC Form 13F filings · as of 2026-06-30